NCT02612246 - First-in-Human Single and Multiple Dose of GLPG1972 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

July 31, 2016

Conditions

Healthy

Interventions

DRUG

GLPG1972 single ascending doses

single dose, oral solution

DRUG

Placebo single dose

single dose, oral solution, matching placebo

DRUG

GLPG1972 multiple ascending doses

multiple doses, daily for 14 days, oral solution

DRUG

Placebo multiple doses

multiple doses, daily for 14 days, oral solution

Trial Locations (1)

SGS LSS Clinical Pharmacology Unit Antwerp, Antwerp